Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HCM - Hypertrophic Non-Obstructive Cardiomyopathy”

32 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 32 results

Testing effectiveness (Phase 2)Study completedNCT01150461
What this trial is testing

Effect of Losartan in Patients With Nonobstructive Hypertrophic Cardiomyopathy

Who this might be right for
Hypertrophic Cardiomyopathy
Massachusetts General Hospital 20
Not applicableStudy completedNCT01631006
What this trial is testing

Effects of Continous Positive Airway Pressure (CPAP) in Hypertrophic Cardiomyopathy

Who this might be right for
Non-obstructive Hypertrophic CardiomyopathyObstructive Hypertrophic Cardiomyopathy
University of Sao Paulo 26
Large-scale testing (Phase 3)Looking for participantsNCT06481891
What this trial is testing

Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy

Who this might be right for
Obstructive Cardiomyopathy, HypertrophicNon-obstructive Hypertrophic Cardiomyopathy
Lexicon Pharmaceuticals 500
Testing effectiveness (Phase 2)Looking for participantsNCT07023614
What this trial is testing

A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy

Who this might be right for
Non-obstructive Hypertrophic Cardiomyopathy
Imbria Pharmaceuticals, Inc. 165
Testing effectiveness (Phase 2)Study completedNCT04826185
What this trial is testing

Evaluate the Safety, Tolerability, and Efficacy of IMB-1018972 in Patients With Non-obstructive Hypertrophic Cardiomyopathy Trial

Who this might be right for
Non-obstructive Hypertrophic Cardiomyopathy
Imbria Pharmaceuticals, Inc. 67
Not applicableLooking for participantsNCT07420907
What this trial is testing

Study of the Progression of Chronic Cardiovascular Conditions

Who this might be right for
Cardiovascular Disease (CVD)Heart FailureAortic Stenosis+9 more
Prolaio 5,000
Testing effectiveness (Phase 2)Study completedNCT04219826
What this trial is testing

Dose-finding Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CK-3773274 in Adults With Hypertrophic Cardiomyopathy

Who this might be right for
Hypertrophic Cardiomyopathy (HCM)
Cytokinetics 96
Not applicableUnknownNCT05952154
What this trial is testing

Transapical Beating-Heart Septal Myectomy in Patients With Symptomatic Nonobstructive Hypertrophic Cardiomyopathy

Who this might be right for
Nonobstructive Hypertrophic Cardiomyopathy
Xiang Wei 100
Very early researchLooking for participantsNCT06433050
What this trial is testing

Sodium Glucose Co-transporter (SGLT) Inhibitors in Nonobstructive Hypertrophic Cardiomyopathy

Who this might be right for
Hypertrophic Cardiomyopathy Without Obstruction
University of Pennsylvania 26
Testing effectiveness (Phase 2)UnknownNCT00430833
What this trial is testing

CHANCE - Candesartan in Hypertrophic Cardiomyopathy

Who this might be right for
Hypertrophic Cardiomyopathy
Charles University, Czech Republic
Post-approval studies (Phase 4)Looking for participantsNCT05569382
What this trial is testing

Treatment Effects of Bisoprolol and Verapamil in Symptomatic Patients With Non-obstructive Hypertrophic Cardiomyopathy

Who this might be right for
Non-obstructive Hypertrophic Cardiomyopathy
Morten Steen Kvistholm Jensen 100
Not applicableActive Not RecruitingNCT05648825
What this trial is testing

Transapical Beating-Heart Septal Myectomy for Symptomatic Nonobstructive Hypertrophic Cardiomyopathy

Who this might be right for
Nonobstructive Hypertrophic Cardiomyopathy
Xiang Wei 100
Large-scale testing (Phase 3)Active Not RecruitingNCT06081894
What this trial is testing

Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic nHCM

Who this might be right for
Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy
Cytokinetics 500
Post-approval studies (Phase 4)Looking for participantsNCT06580717
What this trial is testing

ENavogliflozin DElivering Alleviation of Ventricular Diastolic Dysfunction in nonObstRuctive Hypertrophic CardioMyopathy

Who this might be right for
Nonobstructive Hypertrophic Cardiomyopathy
Yonsei University 200
Not applicableLooking for participantsNCT07595354
What this trial is testing

Exercise Prescription in Children With Hypertrophic Cardiomyopathy

Who this might be right for
Hypertrophic Cardiomyopathy Without Obstruction
Alder Hey Children's NHS Foundation Trust 10
Large-scale testing (Phase 3)Study completedNCT05582395
What this trial is testing

Mavacamten in Non-Obstructive Hypertrophic Cardiomyopathy

Who this might be right for
Cardiomyopathy, Hypertrophic
Bristol-Myers Squibb 580
Not applicableLooking for participantsNCT05818605
What this trial is testing

Exercise Intolerance in Non-obstructive Hypertrophic Cardiomyopathy

Who this might be right for
Hypertrophic Cardiomyopathy
University of California, San Francisco 70
Not applicableEnded earlyNCT07155434
What this trial is testing

ENABLE-HCM - AI-ENabled Echocardiography With Ultrasound Beyond the Echo Lab for Better HCM Imaging and Expanded Access

Who this might be right for
Hypertrophic Cardiomyopathy (HCM)Cardiac ImagingEchocardiography+2 more
UltraSight 36
Testing effectiveness (Phase 2)Study completedNCT03442764
What this trial is testing

Mavacamten in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)

Who this might be right for
Non-obstructive Hypertrophic Cardiomyopathy
MyoKardia, Inc. 59
Testing effectiveness (Phase 2)Study completedNCT03953989
What this trial is testing

Effects of Ranolazine on Coronary Microvascular Dysfunction in Patients With Hypertrophic Cardiomyopathy

Who this might be right for
HCM - Hypertrophic Non-Obstructive Cardiomyopathy
IRCCS San Raffaele 26
Load More Results